Nutanix Inc (NASDAQ:NTNX) Expected to Post Quarterly Sales of $342.04 Million

Equities analysts expect Nutanix Inc (NASDAQ:NTNX) to post sales of $342.04 million for the current fiscal quarter, Zacks reports. Nine analysts have made estimates for Nutanix’s earnings, with estimates ranging from $339.10 million to $346.29 million. Nutanix posted sales of $335.36 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 2%. The firm is expected to announce its next quarterly earnings report on Thursday, February 27th.

On average, analysts expect that Nutanix will report full year sales of $1.39 billion for the current year, with estimates ranging from $1.38 billion to $1.42 billion. For the next financial year, analysts anticipate that the company will report sales of $1.73 billion, with estimates ranging from $1.68 billion to $1.81 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Nutanix.

Nutanix (NASDAQ:NTNX) last released its earnings results on Monday, November 25th. The technology company reported ($0.71) EPS for the quarter, topping analysts’ consensus estimates of ($1.13) by $0.42. Nutanix had a negative net margin of 61.10% and a negative return on equity of 236.32%. The company had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $306.42 million. During the same quarter last year, the business earned ($0.13) EPS. The firm’s revenue was up .5% compared to the same quarter last year.

NTNX has been the topic of a number of recent analyst reports. Morgan Stanley raised their target price on shares of Nutanix from $29.00 to $33.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 26th. Royal Bank of Canada cut their price objective on shares of Nutanix from $39.00 to $32.00 and set an “outperform” rating for the company in a report on Wednesday, August 28th. Robert W. Baird reaffirmed an “outperform” rating and set a $38.00 price objective (up from $29.00) on shares of Nutanix in a report on Tuesday, November 26th. Zacks Investment Research raised shares of Nutanix from a “sell” rating to a “hold” rating and set a $39.00 price objective for the company in a report on Monday, December 2nd. Finally, Wells Fargo & Co increased their price objective on shares of Nutanix from $25.00 to $38.00 and gave the company a “market perform” rating in a report on Tuesday, November 26th. Nine investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $40.44.

NASDAQ NTNX traded down $0.97 on Tuesday, reaching $34.60. 3,265,881 shares of the stock were exchanged, compared to its average volume of 3,987,081. Nutanix has a one year low of $17.74 and a one year high of $54.68. The firm has a market capitalization of $6.72 billion, a PE ratio of -10.88 and a beta of 1.45. The company’s 50-day simple moving average is $29.99 and its two-hundred day simple moving average is $26.53. The company has a current ratio of 2.13, a quick ratio of 2.13 and a debt-to-equity ratio of 2.46.

In related news, CEO Dheeraj Pandey sold 75,495 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $36.60, for a total value of $2,763,117.00. Following the completion of the transaction, the chief executive officer now directly owns 211,177 shares of the company’s stock, valued at $7,729,078.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO David Sangster sold 5,852 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $26.71, for a total transaction of $156,306.92. Following the completion of the transaction, the chief operating officer now directly owns 32,703 shares of the company’s stock, valued at $873,497.13. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 165,416 shares of company stock valued at $5,617,325. Insiders own 9.79% of the company’s stock.

Hedge funds have recently bought and sold shares of the stock. Millennium Management LLC raised its holdings in shares of Nutanix by 27,099.3% in the third quarter. Millennium Management LLC now owns 1,160,971 shares of the technology company’s stock valued at $30,475,000 after acquiring an additional 1,165,271 shares in the last quarter. Squarepoint Ops LLC bought a new stake in shares of Nutanix in the third quarter valued at about $1,711,000. Granahan Investment Management Inc. MA raised its holdings in shares of Nutanix by 41.3% in the third quarter. Granahan Investment Management Inc. MA now owns 116,853 shares of the technology company’s stock valued at $3,067,000 after acquiring an additional 34,141 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Nutanix by 1.6% in the third quarter. Public Employees Retirement System of Ohio now owns 43,879 shares of the technology company’s stock valued at $1,152,000 after acquiring an additional 709 shares in the last quarter. Finally, California State Teachers Retirement System raised its holdings in shares of Nutanix by 1.4% in the third quarter. California State Teachers Retirement System now owns 225,793 shares of the technology company’s stock valued at $5,927,000 after acquiring an additional 3,107 shares in the last quarter. 65.58% of the stock is owned by hedge funds and other institutional investors.

About Nutanix

Nutanix, Inc, together with its subsidiaries, develops and provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. Its solution addresses a range of workloads, including enterprise applications, databases, virtual desktop infrastructure, unified communications, and big data analytics.

Featured Story: Why is the Consumer Price Index (CPI) important?

Get a free copy of the Zacks research report on Nutanix (NTNX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nutanix (NASDAQ:NTNX)

Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.